Cellular compositions for the treatment of kidney disease and uses thereof
AssigneeThe General Hospital Corporation
InventorM. Amin Arnaout
Life of this patent
Estimating the term…
Abstract
As described in more detail below, the present invention provides cellular compositions for the treatment or prevention of kidney disease. The invention is based, at least in part, on the discovery of a population of cortical peritubular Flk1- and Seal-expressing kidney cells having a high tubulogenic potential.
Claims14
An isolated cell having tubulogenic potential, wherein the cell is Flk1 positive Sca1 positive and CD34 negative.
(canceled)
An isolated adult kidney cell having tubulogenic potential, wherein the cell is Flk1 positive, Sca1 positive, vimentin positive and negative for c-kit, CD34, CD45, CD31, and cytokeratin.
An isolated population of cells having tubulogenic potential, wherein at least 85% of the cells are Flk1 positive Sca1 positive and CD34 negative.
(canceled)
14-42. (canceled)
Dependencies are inferred from the claim text.